High circulating HMGB1 indicates good prognosis in patients with advanced leiomyosarcoma under chemoimmunotherapy
Few clinical studies investigated the putative link between the activation of immunogenic cell death (ICD) and the oncological outcome. Recent data, published in a Phase 1b trial, demonstrated that an ICD-associated surge in the plasma concentration of high-mobility group box 1 (HMGB1) indicates fav...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2024-12-01
|
| Serier: | OncoImmunology |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2432059 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|